title: [Management and prognosis of metastatic ovarian carcinoma from nongenital tract].
abstract: OBJECTIVE
  To study the management and prognosis of nongenital metastatic ovarian carcinoma.
  
  
  METHODS
  Thirty-four patients with nongenital metastatic ovarian carcinoma who were admitted in to Zhongnan Hospital of Wuhan University between 1998 and 2004 were analyzed retrospectively.
  
  
  RESULTS
  The median survival time of group A (optimal cytoreductive surgery), group B (optimal cytoreductive surgery + chemotherapy), group C (sub-optimal cytoreductive surgery) and group D (sub-optimal cytoreductive surgery + chemotherapy) was 5.0, 10.0, 4.0 and 6.5 months, respectively. The difference was significant between groups A and B, B and C, as well as between group C and D (P < 0.05).
  
  
  CONCLUSIONS
  Most of nongenital metastatic ovarian carcinomas come from tumors of stomach and intestine. Optimal cytoreductive surgery and chemotherapy play an important role in the management and prognosis of nongenital metastatic ovarian carcinoma.
authors: Department of Gynecologic Oncology, Zhongnan Hospital, Wuhan University, Wuhan 430071, China.
authors: Xu-feng
authors: XF
authors: Wu
authors: Yi
authors: Y
authors: Chen
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000473:pathology; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000473:pathology*; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000556:secondary* / Q000601:surgery / Q000628:therapy*; D011379:Prognosis; D012189:Retrospective Studies; D055815:Young Adult